Bottom line
How much do JDOC and SWHFX overlap?
57% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 52.8% of JDOC's assets and 53.1% of SWHFX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings JDOC and SWHFX have in common
| Holding | % of JDOC | % of SWHFX | Overlap |
|---|---|---|---|
| AbbVie, Inc. | 7.85% | 5.81% | 5.81% |
| Eli Lilly & Co. | 7.76% | 13.92% | 7.76% |
| UnitedHealth Group, Inc. | 5.85% | 4.74% | 4.74% |
| Merck & Co., Inc. | 4.82% | 4.98% | 4.82% |
| Johnson & Johnson | 4.82% | 6.94% | 4.82% |
| Thermo Fisher Scientific, Inc. | 3.73% | 2.16% | 2.16% |
| Bristol-Myers Squibb Co. | 3.57% | 2.44% | 2.44% |
| Abbott Laboratories | 3.11% | 1.60% | 1.60% |
| Roche Holding AG | 2.82% | 2.29% | 2.29% |
| GSK plc | 2.47% | 1.73% | 1.73% |
| Stryker Corp. | 2.23% | 2.11% | 2.11% |
| Danaher Corp. | 2.16% | 1.47% | 1.47% |
| Novartis AG | 1.60% | 2.92% | 1.60% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in JDOC
- AstraZeneca plc — 3.76%
- CVS Health Corp. — 2.83%
- Novo Nordisk A/S — 2.61%
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- Intuitive Surgical, Inc. — 1.93%
- Edwards Lifesciences Corp. — 1.73%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Regeneron Pharmaceuticals, Inc. — 1.60%
- Biogen, Inc. — 1.56%
- Cardinal Health, Inc. — 1.51%
Only in SWHFX
- Gilead Sciences Inc — 3.24%
- Amgen Inc — 2.58%
- Medtronic PLC — 2.29%
- Vertex Pharmaceuticals Inc — 1.89%
- Boston Scientific Corp — 1.60%
- Cigna Group/The — 1.51%
- Elevance Health Inc — 1.45%
- Incyte Corp — 1.37%
- Ipsen SA — 1.34%
- Sanofi SA — 1.31%
- Becton Dickinson & Co — 1.24%
- Astellas Pharma Inc — 1.19%
Asset mix
| Asset type | JDOC | SWHFX |
|---|---|---|
| Stocks | 99.2% | 99.0% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | JDOC | SWHFX |
|---|---|---|
| US | 75.2% | 78.6% |
| GB | 6.2% | 3.4% |
| CH | 4.4% | 5.2% |
| IE | 0.4% | 4.5% |
| DK | 4.0% | 0.7% |
| FR | — | 2.6% |
| JP | 2.5% | 2.3% |
| NL | 2.4% | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do JDOC and SWHFX overlap?
What stocks do JDOC and SWHFX have in common?
Should I own both JDOC and SWHFX?
Which holds more stocks, JDOC or SWHFX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.